Skip to main content
Completed Consortium

QuPharma: Quantum Enhanced Computing Platform for Pharmaceutical R&D

A SEEQC-led consortium linking a quantum computer with a classical supercomputer to model drug properties.

Project data last updated 11 October 2026

About this project

QuPharma ran from March 2022 to March 2025. Merck was the end user. STFC's Hartree Centre, its Scientific Computing Department and the National Quantum Computing Centre took part.

The stated aim was to speed up parts of drug development by a factor of ten. The first focus was simulation tools for photodynamic cancer therapies.

Lead organisation

SEEQC UK

Company · London

UK arm of SEEQC, maker of superconducting digital control chips for qubits, which led the QuPharma drug-discovery quantum computing project.

Partners (6)

Funders

In the news

Quantum Zeitgeist articles naming the lead organisation or partners. They may not be about this project.

All news for this project and its partners

Sources

  1. Gateway to Research: Quantum Enhanced Computing Platform for Pharmaceutical R&D - QuPharma (gtr.ukri.org)
  2. STFC Hartree Centre: £50m funding for UK quantum computing projects with industry (hartree.stfc.ac.uk)